Implantable miniature telescope for age-related macular degeneration goes to FDA panel
This article was originally published in Clinica
An FDA advisory committee will meet on July 14 to consider whether to recommend approval of an implantable miniature telescope that restores some of the central vision that is lost due to age-related macular degeneration (AMD).
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.